These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21394000)

  • 1. Have we maxed out on new therapies.
    Somberg JC
    Am J Ther; 2011; 18(2):91. PubMed ID: 21394000
    [No Abstract]   [Full Text] [Related]  

  • 2. Past the wall in cardiovascular R&D.
    Topol EJ
    Nat Rev Drug Discov; 2009 Apr; 8(4):259. PubMed ID: 19348004
    [No Abstract]   [Full Text] [Related]  

  • 3. Innovative drug R&D in China.
    Qi J; Wang Q; Yu Z; Chen X; Wang F
    Nat Rev Drug Discov; 2011 May; 10(5):333-4. PubMed ID: 21532556
    [No Abstract]   [Full Text] [Related]  

  • 4. A status report on neuroscience research, without grade inflation.
    Johnston SC; Hauser SL
    Ann Neurol; 2006 Dec; 60(6):A9-11. PubMed ID: 17192939
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical sciences in 2020.
    Crommelin D; Stolk P; Besançon L; Shah V; Midha K; Leufkens H
    Nat Rev Drug Discov; 2010 Feb; 9(2):99-100. PubMed ID: 20118959
    [No Abstract]   [Full Text] [Related]  

  • 6. [The efficacy and safety of the drug treatment of cardiovascular diseases].
    Mazur NA
    Ter Arkh; 1993; 65(8):4-7. PubMed ID: 8211800
    [No Abstract]   [Full Text] [Related]  

  • 7. PHARMAC and cardiovascular health in New Zealand.
    Moodie P
    N Z Med J; 2008 Mar; 121(1270):102-5. PubMed ID: 18364762
    [No Abstract]   [Full Text] [Related]  

  • 8. Facilitating the future.
    Nature; 2008 Dec; 456(7224):837-8. PubMed ID: 19092872
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular drug therapy in the elderly.
    Aronow WS; Frishman WH; Cheng-Lai A
    Heart Dis; 2000; 2(2):151-67. PubMed ID: 11728253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety in clinical trials in cardiovascular disease.
    Cohn JN
    J Am Coll Cardiol; 2006 Aug; 48(3):430-3. PubMed ID: 16875964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connexin 43, a new therapeutic target for cardiovascular diseases.
    Song YN; Zhang H; Zhao JY; Guo XL
    Pharmazie; 2009 May; 64(5):291-5. PubMed ID: 19530438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methods of evaluating drug therapy, particularly in cardiovascular diseases].
    Lövy O; Toman J
    Cesk Zdrav; 1984 Sep; 32(8-9):361-5. PubMed ID: 6509673
    [No Abstract]   [Full Text] [Related]  

  • 13. Translating molecular target into drug therapy in cardiovascular disease.
    Bril A; Avkiran M
    Curr Opin Pharmacol; 2008 Apr; 8(2):111-3. PubMed ID: 18294914
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular combinations.
    Glass G
    Nat Rev Drug Discov; 2004 Sep; 3(9):731-2. PubMed ID: 15368657
    [No Abstract]   [Full Text] [Related]  

  • 15. The future of clinical research.
    Vaitukaitis JL
    Clin Res; 1991 Apr; 39(2):145-56. PubMed ID: 2044346
    [No Abstract]   [Full Text] [Related]  

  • 16. Interesting times.
    Caplan M
    Physiology (Bethesda); 2009 Apr; 24():74. PubMed ID: 19364909
    [No Abstract]   [Full Text] [Related]  

  • 17. Windfall warning.
    Nature; 2009 Oct; 461(7266):847-8. PubMed ID: 19829323
    [No Abstract]   [Full Text] [Related]  

  • 18. European Society of Cardiology--2009 annual congress. 31 August - 2 September 2009, Barcelona, Spain.
    Wong NC
    IDrugs; 2009 Nov; 12(11):675-8. PubMed ID: 19844849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wanted: scientists to shape Europe's future research policy.
    Abbott A
    Nature; 2005 May; 435(7039):135. PubMed ID: 15889056
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiology drug update. Foreword.
    Crawford MH
    Cardiol Clin; 2008 Nov; 26(4):xi. PubMed ID: 18929226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.